Approximately 401,000 people in Colorado, or 9.3 percent
of the adult population, have diabetes/h2>
Endocrine Explained
Audience:
Primary care providers (MD, DO, APP NP, PA)
Commitment:
Eleven weekly ECHO sessions held virtually
Wednesdays 12:00 - 1:00 PM MT
August 2 - October 18
No session September 20
CME:
Our application is pending approval. Participants should claim only the credit commensurate with the extent of their participation in the series (1.0 credit per session attended). To claim CME credit, participants who attend at least one session must complete the post-series survey, which will be sent on the day of the last session (October 18).
In partnership with:
University of Colorado School of Medicine, Department of Endocrinology
-
ECHO SESSION 1
Metabolic Bone Disease Cases
August 2, 2023
-
ECHO SESSION 2
Osteoporosis Management
August 9, 2023
-
ECHO SESSION 3
Secondary Osteoporosis
August 16, 2023
-
ECHO SESSION 4
Hypercalcemia
August 23, 2023
-
ECHO SESSION 5
Hyperthyroidism
August 30, 2023
-
ECHO SESSION 6
Abnormal thyroid function tests (cases)
September 6, 2023
-
ECHO SESSION 7
Thyroid nodules and thyroid malignancy
September 13, 2023
-
ECHO SESSION 8
Adrenal nodules and endocrine hypertension
September 27, 2023
-
ECHO SESSION 9
Pituitary Tumors
October 4, 2023
-
ECHO SESSION 10
Hypogonadism
October 11, 2023
-
ECHO SESSION 11
Anti-Obesity Pharmacotherapy
October 18, 2023